Kickstart your portfolio with a U.S. stock on us
Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Moleculin Biotech, Inc.
About MBRX
Moleculin Biotech, Inc. is a Phase III clinical-stage pharmaceutical company advancing a pipeline of therapeutic candidates addressing tumors and viruses. The Company is conducting a pivotal Phase III trial evaluating Annamycin, a non-cardiotoxic anthracycline, in combination with Cytarabine for the treatment of subjects with relapsed/refractory acute myeloid leukemia (AML). It has three core technologies and six drug candidates, three of which have shown human activity in clinical trials. Its core technologies consist of Annamycin, WP1066 Portfolio, and WP1122 Portfolio. Annamycin is designed to avoid multidrug resistance mechanisms and cardiotoxicity. Its WP1066, is an Immune/Transcription Modulator capable of inhibiting p-STAT3 and other transcription factors, and its portfolio includes WP1193, and WP1220. Its WP1122 contains compounds including WP1096, and WP1097, which is designed to exploit the potential uses of inhibitors of glycolysis such as 2-deoxy-D-glucose (2-DG).
Find out what a historical investment in Moleculin Biotech, Inc. would be worth today using our MBRX stock calculator.
Market Capitalisation
$11.26M
Price-earnings ratio
-
Dividend yield
0.00%
Volume
312.13K
High today
$2.18
Low today
$2.01
Open price
$2.16
52-week high
$25.00
52-week low
$1.79
Ready to start your investing journey with Stake?
Open an accountHow do I buy MBRX shares in Australia?
Buying MBRX shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Moleculin Biotech, Inc. in minutes.
- Sign up with some I.D. and zero paperwork
- Add funds to your account
- Make your first investment in MBRX
What is the ticker symbol of Moleculin Biotech, Inc.?
The ticker symbol for Moleculin Biotech, Inc. is MBRX.
How much is one share of MBRX?
One share of MBRX is valued at $0.00 as of 16 May 2026.
What is the market capitalisation of Moleculin Biotech, Inc. MBRX?
As of 16 May 2026 Moleculin Biotech, Inc. has a market cap of $11.26M.
What is the 52-week high for Moleculin Biotech, Inc. stock?
The Moleculin Biotech, Inc. 52-week high stock price is $25.00.
What is the 52-week low for Moleculin Biotech, Inc. stock?
The Moleculin Biotech, Inc. 52-week low stock price is $1.79.
Can I buy MBRX shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy MBRX shares and over 12,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in MBRX on Stake
- Buy MBRX from US$3 brokerage
- Invest in 9,500+ U.S. stocks and ETFs
- Own a slice of MBRX from only US$10 with fractional shares
Stock shown for demonstrative purposes only. US$3 brokerage up to US$30,000.
MBRX related stocks